Tran N, Chang T, Chi N, Lai K, Chen H, Fong Y
Int J Biol Sci. 2025; 21(3):1144-1157.
PMID: 39897041
PMC: 11781170.
DOI: 10.7150/ijbs.106827.
Hashim G, Shahgolzari M, Hefferon K, Yavari A, Venkataraman S
Bioengineering (Basel). 2025; 12(1).
PMID: 39851281
PMC: 11759177.
DOI: 10.3390/bioengineering12010007.
Alqarni A, Hosmani J, Alassiri S, A Alqahtani A, Assiri H
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458948
PMC: 11510435.
DOI: 10.3390/ph17101309.
Dvorska D, Mazurakova A, Lackova L, Sebova D, Kajo K, Samec M
Front Oncol. 2024; 14:1463656.
PMID: 39435289
PMC: 11491292.
DOI: 10.3389/fonc.2024.1463656.
Li W, Jiang H, Zhang W, Sun Q, Zhang Q, Xu J
Front Pharmacol. 2024; 15:1407525.
PMID: 39318781
PMC: 11420528.
DOI: 10.3389/fphar.2024.1407525.
Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells.
Mazurakova A, Koklesova L, Vybohova D, Samec M, Kudela E, Biringer K
Front Pharmacol. 2023; 14:1160068.
PMID: 37089930
PMC: 10115970.
DOI: 10.3389/fphar.2023.1160068.
Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells - A potential contribution to the predictive, preventive, and personalized medicine.
Mazurakova A, Koklesova L, Csizmar S, Samec M, Brockmueller A, Sudomova M
J Adv Res. 2023; 55:103-118.
PMID: 36871616
PMC: 10770105.
DOI: 10.1016/j.jare.2023.02.015.
Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation.
Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo T
EPMA J. 2023; 14(1):21-42.
PMID: 36866156
PMC: 9971534.
DOI: 10.1007/s13167-023-00314-8.
Natural Products as Anticancer Agents: Current Status and Future Perspectives.
Naeem A, Hu P, Yang M, Zhang J, Liu Y, Zhu W
Molecules. 2022; 27(23).
PMID: 36500466
PMC: 9737905.
DOI: 10.3390/molecules27238367.
Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.
Mazurakova A, Samec M, Koklesova L, Biringer K, Kudela E, Al-Ishaq R
EPMA J. 2022; 13(3):461-486.
PMID: 35821883
PMC: 9263437.
DOI: 10.1007/s13167-022-00288-z.
Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper.
Golubnitschaja O, Kubatka P, Mazurakova A, Samec M, Alajati A, Giordano F
Cancers (Basel). 2022; 14(3).
PMID: 35158943
PMC: 8833369.
DOI: 10.3390/cancers14030675.
Screening of and Plants and Identification of Major Phytometabolites in Potential Plant Extracts Responsible for Apoptosis Induction in Skin Melanoma and Lung Adenocarcinoma Cells.
Kaushik N, Oh H, Lim Y, Kaushik N, Nguyen L, Choi E
Front Bioeng Biotechnol. 2021; 9:779393.
PMID: 34957073
PMC: 8704398.
DOI: 10.3389/fbioe.2021.779393.
Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM proposition to mitigate individual risks.
Liskova A, Koklesova L, Samec M, Abdellatif B, Zhai K, Siddiqui M
EPMA J. 2021; 12(3):325-347.
PMID: 34367380
PMC: 8329620.
DOI: 10.1007/s13167-021-00249-y.
Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles.
Liskova A, Samec M, Koklesova L, Brockmueller A, Zhai K, Abdellatif B
EPMA J. 2021; 12(2):155-176.
PMID: 34025826
PMC: 8126506.
DOI: 10.1007/s13167-021-00242-5.
Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine.
Liskova A, Samec M, Koklesova L, Kudela E, Kubatka P, Golubnitschaja O
Int J Mol Sci. 2021; 22(4).
PMID: 33670490
PMC: 7922866.
DOI: 10.3390/ijms22042007.
Anti-Tumor Activity of L. and Hyperforin through Modulation of Inflammatory Signaling, ROS Generation and Proton Dynamics.
Menegazzi M, Masiello P, Novelli M
Antioxidants (Basel). 2020; 10(1).
PMID: 33379141
PMC: 7824709.
DOI: 10.3390/antiox10010018.
Carotenoids in Cancer Metastasis-Status Quo and Outlook.
Koklesova L, Liskova A, Samec M, Zhai K, Abotaleb M, Ashrafizadeh M
Biomolecules. 2020; 10(12).
PMID: 33321708
PMC: 7763577.
DOI: 10.3390/biom10121653.
The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis.
Samec M, Liskova A, Koklesova L, Samuel S, Murin R, Zubor P
J Cancer Res Clin Oncol. 2020; 146(12):3137-3154.
PMID: 33063131
DOI: 10.1007/s00432-020-03424-2.
Phyto-Immunotherapy, a Complementary Therapeutic Option to Decrease Metastasis and Attack Breast Cancer Stem Cells.
Fiorentino S, Uruena C, Lasso P, Prieto K, Barreto A
Front Oncol. 2020; 10:1334.
PMID: 32850424
PMC: 7426739.
DOI: 10.3389/fonc.2020.01334.
Cytotoxic Phenanthrene, Dihydrophenanthrene, and Dihydrostilbene Derivatives and Other Aromatic Compounds from .
Bisoli E, Freire T, Yoshida N, Garcez W, Queiroz L, Matos M
Molecules. 2020; 25(14).
PMID: 32664233
PMC: 7397156.
DOI: 10.3390/molecules25143154.